Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
Based on their tunable physicochemical properties and the possibility of producing cell-specific platforms through surface modification with functional biomolecules, nanoparticles (NPs) represent highly promising tools for biomedical applications. To improve their potential under physiological conditions and to enhance their cellular uptake, combinations with cell-penetrating peptides (CPPs) represent a valuable strategy. CPPs are often cationic peptide sequences that are able to translocate across biological membranes and to carry attached cargos inside cells and have thus been recognized as versatile tools for drug delivery. Nevertheless, the conjugation of CPP to NP surfaces is dependent on many properties from both individual components, and further insight into this complex interplay is needed to allow for the fabrication of highly stable but functional vectors. Since CPPs per se are nonselective and enter nearly all cells likewise, additional decoration of NPs with homing devices, such as tumor-homing peptides, enables the design of multifunctional platforms for the targeted delivery of chemotherapeutic drugs. In this review, we have updated the recent advances in the field of CPP-NPs, focusing on synthesis strategies, elucidating the influence of different physicochemical properties, as well as their application in cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · cited 2×
“In fact, their fate is highly influenced by their physicochemical properties, such as particle size and surface modification, that determine the biodistribution, blood circulation time, protein corona formation, toxicity, and immunological response [52].”
BackgroundDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“The tunable physicochemical properties, which rely mainly on the choice of lipid and the preparation method, along with their high biocompatibility has led to the first FDA approved nano-drug in 1995, Doxil®, doxorubicin-loaded liposome [34].”
BackgroundAtomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
Jin, R., Zeng, C., Zhou, M., & Chen, Y. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00703 · Cited by 3,459 · cited 1×
“The occurrence of size- and shape-dependent surface plasmon resonance (SPR) has led to the fabrication of gold NPs in various sizes and shapes, including rod-shaped, star-shaped, and nanoshells [41].”
BackgroundNear-infrared fluorophores for biomedical imaging
Hong, G., Antaris, A. L., & Dai, H. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0010 · Cited by 2,985 · cited 1×
“Other near infrared-emitting structures, such as carbon nanotubes or lanthanide-doped NPs, are likewise useful for bioimaging and PTT applications; however, their potential toxicity has so far limited their employment in clinical trials [43].”
BackgroundCellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
BackgroundThe third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791 · cited 1×
“The controlled killing of diseased cells is commonly performed through the application of heat (photothermal therapy, hyperthermia), ultrasound, radiation, activation of reactive oxygen species (photodynamic therapy), gene and immune-modulation, the delivery of high payloads of drug molecules, or combinations thereof…”
BackgroundFutaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
BackgroundEndosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561 · cited 1×
“Following this mediates endosomal swelling and disruption with the final release of the entrapped cargo [20].”
BackgroundGreen, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
Background
Cited by
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Sousa de Almeida, M., Susnik, E., Drasler, B., Taladriz-Blanco, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,079
A Global Review on Short Peptides: Frontiers and Perspectives
Apostolopoulos, V., Bojarska, J., Chai, T.-T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Lopez, O. P., Parhiz, H., et al. (2021) · Molecules · doi:10.3390/molecules26020430 · Cited by 421
“homing peptides is an attractive avenue for tumor-targeted therapy [136,137].”
BackgroundBiomedical applications of copper-free click chemistry: in vitro, in vivo, and ex vivo
Kim, E., & Koo, H. (2019) · Chemical Science · doi:10.1039/c9sc03368h · Cited by 421
Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments
Kolarikova, M., Hosikova, B., Dilenko, H., Barton‐Tomankova, K., Valkova, L., Bajgar, R., Malina, L., & Kolarova, H. (2023) · Medicinal Research Reviews · doi:10.1002/med.21935 · Cited by 282
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
Zoulikha, M., Xiao, Q., Boafo, G. F., Sallam, M. A., Chen, Z., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.009 · Cited by 275
A Comprehensive Review of Nanomaterials: Types, Synthesis, Characterization, and Applications
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac131.041 · Cited by 269
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
El‐Hammadi, M. M., & Arias, J. L. (2022) · Nanomaterials · doi:10.3390/nano12030354 · Cited by 172
Rosero, W. A. A., Barbezan, A. B., de Souza, C. D., & Rostelato, M. E. C. M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020255 · Cited by 169
“Exploiting the Warburg effect, where cancer cells exhibit a preference for glucose metabolism over oxidative phosphorylation, carbohydrates can actively target cancer cells, capitalizing on the overexpression of sugar transporters in these cells.”
BackgroundMesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect
Frickenstein, A. N., Hagood, J. M., Britten, C. N., Abbott, B. S., McNally, M. W., Vopat, C. A., Patterson, E. G., MacCuaig, W. M., Jain, A., Walters, K. B., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040570 · Cited by 147
Cell-penetrating peptides in protein mimicry and cancer therapeutics
Zorko, M., Jones, S., & Langel, Ü. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114044 · Cited by 141
Majeed, S., Saravanan, M., Danish, M., Zakariya, N. A., Ibrahim, M. N. M., Rizvi, E. H., NisaAndrabi, S. U., Barabadi, H., Mohanta, Y. K., & Mostafavi, E. (2022) · Talanta · doi:10.1016/j.talanta.2022.124026 · Cited by 127
From 2D to 3D Cancer Cell Models—The Enigmas of Drug Delivery Research
Van Zundert, I., Fortuni, B., & Rocha, S. (2020) · Nanomaterials · doi:10.3390/nano10112236 · Cited by 107
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment
Han, X., Gong, C., Yang, Q., Zheng, K., Wang, Z., & Zhang, W. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442877 · Cited by 121
“56,57 Multidrug Resistance from Drug Efflux Pumps Multidrug resistance (MDR) in tumor cells is the main obstacle to the failure of chemotherapy for cancer treatment.”
BackgroundReview: Nanoparticles can change (bio)hydrogen competitiveness
Maroušek, J. (2022) · Fuel · doi:10.1016/j.fuel.2022.125318 · Cited by 109
Surface design of nanocarriers: Key to more efficient oral drug delivery systems
Spleis, H., Sandmeier, M., Claus, V., & Bernkop‐Schnürch, A. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102848 · Cited by 102
Nanoparticle entry into cells; the cell biology weak link
Griffiths, G. W., Grüenberg, J., Marsh, M., Wohlmann, J., Jones, A. T., & Parton, R. G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114403 · Cited by 104
Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications
Živojević, K., Mladenović, M., Djisalov, M., Mundžić, M., Ruiz‐Hernández, E., Gadjanski, I., & Knežević, N. Ž. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.029 · Cited by 99
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives
Rehan, F., Zhang, M., Fang, J. Q., & Greish, K. F. (2024) · Molecules · doi:10.3390/molecules29092073 · Cited by 107
“[137].”
Friedl, J. D., Nele, V., Rosa, G. D., & Bernkop‐Schnürch, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202103347 · Cited by 95
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
Hueso, M., Mallén, A., Suñé-Pou, M., Aran, J. M., Suñé-Negre, J. M., & Navarro, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111596 · Cited by 97
Photoresponsive Drug Delivery Systems: Challenges and Progress
Yang, Y., Long, K., Chu, Y., Lu, H., Wang, W., & Zhan, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402975 · Cited by 93
Dendrimers as Modifiers of Inorganic Nanoparticles for Therapeutic Delivery in Cancer
Zenze, M., Daniels, A. N., & Singh, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020398 · Cited by 69
“Inorganic NPs have been extensively used in a wide range of biomedical applications, including magnetic resonance imaging (MRI) [1–4], drug release [9,10], gene transfer [11,12], biosensing [13,14], immobilization of proteins and enzymes [15,16], various cancer treatments, and cell separation [17,18].”
BackgroundImpact of nanotechnology on the oral delivery of phyto-bioactive compounds
Nsairat, H., Lafi, Z., Al-Sulaibi, M., Gharaibeh, L. F., & Alshaer, W. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.136438 · Cited by 73
Sun, Z., Huang, J., Fishelson, Z., Wang, C., & Zhang, S. (2023) · Biomedicines · doi:10.3390/biomedicines11071971 · Cited by 71
“Non-viral delivery vehicles can be divided into three categories: (1) organic nanovehicles; (2) inorganic nanovehicles; and (3) composite nanoparticles [21].”
BackgroundInfluentialPeptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Branco, F., Cunha, J., Mendes, M., Vitorino, C., & Sousa, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c01790 · Cited by 65
Graphene-Oxide Peptide-Containing Materials for Biomedical Applications
Gostaviceanu, A., Gavrilaş, S., Copolovici, L. O., & Copolovici, D. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810174 · Cited by 61
“This review provides a comprehensive overview of recent advancements and explores new functionalization strategies for GO–peptide conjugates [10], emphasizing the need for ongoing research to address safety and efficacy concerns.”
BackgroundInfluentialRecent Advances of Studies on Cell-Penetrating Peptides Based on Molecular Dynamics Simulations
Ouyang, J., Sheng, Y., & Wang, W. (2022) · Cells · doi:10.3390/cells11244016 · Cited by 65
Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
Fattal, E., & Fay, F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.019 · Cited by 60
Pegoraro, C., Domingo-Ortí, I., Conejos‐Sánchez, I., & Vicent, M. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115195 · Cited by 59
Epigenetic editing: Dissecting chromatin function in context
Policarpi, C., Dabin, J., & Hackett, J. A. (2021) · BioEssays · doi:10.1002/bies.202000316 · Cited by 56
Persano, F., Batasheva, S., Fakhrullina, G., Gigli, G., Leporatti, S., & Fakhrullin, R. F. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02957b · Cited by 54
A state-of-the-art on the application of nanotechnology for enhanced biohydrogen production
Balakumar, K., & Velvizhi, G. (2023) · International Journal of Hydrogen Energy · doi:10.1016/j.ijhydene.2023.04.237 · Cited by 57
Recent advances in carbon quantum dots for gene delivery: A comprehensive review
Othman, H. O., Anwer, E. T., Ali, D. S., Hassan, R. O., Mahmood, E. E., Ahmed, R. A., Muhammad, R. F., & Smaoui, S. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31236 · Cited by 50
“They can be engineered to selectively engage with particular cell types or metabolic networks, hence enhancing therapeutic results (Gessner & Neundorf, 2020).”
Pirhaghi, M., Mamashli, F., Moosavi-Movahedi, F., Arghavani, P., Amiri, A., Davaeil, B., Mohammad-Zaheri, M., Mousavi-Jarrahi, Z., Sharma, D., Langel, Ü., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01167 · Cited by 51
Silvestre, A. L. P., Filippo, L. D. D., Besegato, J. F., de Annunzio, S. R., de Camargo, B. A. F., de Melo, P. B. G., Rastelli, A. N. D. S., Fontana, C. R., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120078 · Cited by 46
Sachdeva, V., Monga, A., Vashisht, R., Singh, D., Singh, A., & Bedi, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103585 · Cited by 47
Samal, P., Satpathy, S., Panigrahi, L. L., Jha, S., & Arakha, M. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00076a · Cited by 47
Liu, Y., Zhao, Z., & Li, M. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.05.002 · Cited by 69
Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections
Khairkhah, N., Namvar, A., & Bolhassani, A. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00679-1 · Cited by 46
“Although the next challenge of designing suitable CPPs is to find proper engineering techniques to control the morphology to improve selectivity and specificity [165].”
BackgroundApplications of cell penetrating peptide-based drug delivery system in immunotherapy
Du, J., Zhang, R., Jiang, S., Xiao, S., Liu, Y., Niu, Y., Zhao, W.-X., Wang, D., & Ma, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1540192 · Cited by 48
Zorko, M., & Langel, Ü. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1752-6_1 · Cited by 44
Akobundu, U. U., Ifijen, I. H., Duru, P., Igboanugo, J. C., Ekanem, I., Fagbolade, M., Ajayi, A. S., George, M., Atoe, B., & Matthews, J. T. (2025) · RSC Advances · doi:10.1039/d5ra00308c · Cited by 42
Liu, X., Zhao, Z., Sun, X., Wang, J., Yi, W., Wang, D., & Li, Y. (2022) · Small Methods · doi:10.1002/smtd.202200898 · Cited by 41
Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry
Gomes, M., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050661 · Cited by 43
“Penetratin peptide, derived from the Antennapedia homeodomain, is a well-established CPP that enhances translocation across cellular membranes, thereby improving the intracellular delivery of therapeutic agents [96,97].”
Studies of cell-penetrating peptides by biophysical methods
Zorko, M., & Langel, Ü. (2022) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583522000026 · Cited by 38
Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development
Mulay, A. R., Hwang, J., & Kim, D. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303180 · Cited by 39
Ilieş, B. D., Yıldız, İ., & Abbas, M. (2024) · ChemBioChem · doi:10.1002/cbic.202300867 · Cited by 40
Zhu, C., Mu, J., & Liang, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02969-5 · Cited by 42
Approaches for the discovery of new cell-penetrating peptides
Porosk, L., Gaidutšik, I., & Langel, Ü. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1851187 · Cited by 37
“For example, the efficacy of CPP sC18 attached to silica nanoparticles was investigated by an alanine scan, by substituting each of the 16 amino acids systematically with an alanine residue [53].”
MethodConte, C., Longobardi, G., Barbieri, A., Palma, G., Luciano, A., Poggetto, G. D., Avitabile, C., Pecoraro, A., Russo, A., Russo, G., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122618 · Cited by 35
Targeting nanoparticles to malignant tumors
Sharma, N., Bietar, K., & Stochaj, U. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188703 · Cited by 40
Lee, H., & Noh, H. (2023) · Gels · doi:10.3390/gels9090718 · Cited by 34
Progress in tumour-targeted drug delivery based on cell-penetrating peptides
Kong, X., Xu, J., Yang, X., Zhai, Y., Ji, J., & Zhai, G. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1920026 · Cited by 30
Sepsis diagnosis and treatment using nanomaterials
Lim, J., Lee, Y. Y., Choy, Y. B., Park, W., & Park, C. G. (2021) · Biomedical Engineering Letters · doi:10.1007/s13534-021-00200-0 · Cited by 34
“The polymeric NPs can specific targeting, protection of drug molecules, ability to combine therapy and imaging, controlled release, and surface functionalization through diverse precursors [67, 68].”
BackgroundMakvandi, P., Zarepour, A., Zheng, X.-Q., Agarwal, T., Ghomi, M., Sartorius, R., Zare, E. N., Zarrabi, A., Wu, A., Maiti, T. K., et al. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101107 · Cited by 33
Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA
Zhang, X., Cai, A., Gao, Y., Zhang, Y., Duan, X., & Men, K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00316 · Cited by 31
Supramolecular Peptide Nanofiber/PLGA Nanocomposites for Enhancing Pulmonary Drug Delivery
Chintapula, U. K., Yang, S., Nguyen, T., Li, Y., Jaworski, J. W., Dong, H., & Nguyen, K. T. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c15204 · Cited by 30
Milewska, S., Sadowska, A. J., Stefaniuk, N., Misztalewska‐Turkowicz, I., Wilczewska, A. Z., Car, H., & Niemirowicz-Laskowska, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116219 · Cited by 34
“Thus, it was proved that the addition of a tumor-penetrating peptide to the surface of nanoparticles can enhance their specific properties such as cancer selectivity, tissue penetration, and potency [113,114].”
BackgroundPeptide-Assisted Nucleic Acid Delivery Systems on the Rise
Tarvirdipour, S., Skowicki, M., Schoenenberger, C., & Palivan, C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169092 · Cited by 30
“TAT and penetratin, the first cationic CPPs discovered, have been widely used to promote cellular uptake and transfection efficiency of various lipid, polymer, and peptide-based nanocar-riers [119–121].”
BackgroundNanomedicine Approaches to Negotiate Local Biobarriers for Topical Drug Delivery
Mustfa, S. A., Maurizi, E., McGrath, J. A., & Chiappini, C. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000160 · Cited by 33
Development of Peptide-Based Nanoparticles for Mitochondrial Plasmid DNA Delivery
Faria, R., Vivès, É., Boisguérin, P., Sousa, Â., & Costa, D. R. B. (2021) · Polymers · doi:10.3390/polym13111836 · Cited by 30
Galindo, R., Haro, I., Gomara, M. J., Espina, M., Fonseca, J., Martins‐Gomes, C., Camins, A., Silva, A. M., García, M. L., & Souto, E. B. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122982 · Cited by 27
Manikkath, J., Jishnu, P. V., Wich, P. R., Manikkath, A., & Radhakrishnan, R. A. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0381 · Cited by 28
Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy
Andrés, C. M. C., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Pérez‐Lebeña, E. (2024) · Cancers · doi:10.3390/cancers16183123 · Cited by 30
Approaches for evaluation of novel CPP-based cargo delivery systems
Porosk, L., & Langel, Ü. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1056467 · Cited by 31
“CPPs have been associated with the NPs by electrostatic interactions, covalent linking or even as an additive (Váňová et al., 2019; Gessner and Neundorf, 2020).”
BackgroundBreaking Barriers: Nanomedicine-Based Drug Delivery for Cataract Treatment
Chen, Y., Ye, Z., Chen, H., & Li, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s463679 · Cited by 26
“12 This review delineates the restrictions imposed by anatomical and physiological ocular barriers and presents the utilization of diverse cutting-edge drug delivery systems in cataract treatment (Figure 1).”
BackgroundAdvancement of nanoscience in development of conjugated drugs for enhanced disease prevention
Taneja, P., Sharma, S., Sinha, V. B., & Yadav, A. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118859 · Cited by 26
Alvand, Z. M., Rahimi, M., & Rafati, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124257 · Cited by 23
Fabrication techniques for the preparation of orally administered insulin nanoparticles
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1817042 · Cited by 23
Jabeen, M., Biswas, P., Islam, M. T., & Paul, R. (2023) · Viruses · doi:10.3390/v15030640 · Cited by 23
“Silver nanoparticles (AgNPs) have shown significant efficacy against bacteria, vi‐ ruses, and even eukaryotic organisms [44].”
InfluentialActivatable luminescent probes for imaging brain diseases
Li, Z., Wang, C., Zhang, M., Li, S., Mao, Z., & Liu, Z. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101239 · Cited by 23
Arib, C., Griveau, A., Eyer, J., & Spadavecchia, J. (2022) · Nanoscale Advances · doi:10.1039/d2na00096b · Cited by 22
Elizarova, T. N., Antopolsky, M. L., Novichikhin, D. O., Skirda, A. M., Орлов, А. В., Bragina, V. A., & Nikitin, P. I. (2023) · Molecules · doi:10.3390/molecules28083318 · Cited by 22
Recent Advances in Targeted Nanotherapeutic Approaches for Breast Cancer Management
Gupta, P., Neupane, Y. R., Parvez, S., & Kohli, K. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0281 · Cited by 26
Jeune, M. L., Secret, E., Trichet, M., Michel, A., Ravault, D., Illien, F., Siaugue, J., Sagan, S., Burlina, F., & Ménager, C. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c01346 · Cited by 24
Nanomaterial-mediated photoporation for intracellular delivery
Wang, L., Wei, X., Liu, H., & Fan, Y. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.12.050 · Cited by 21
Zou, Y., Zhang, J., Chen, L., Xu, Q., Yao, S., & Chen, H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030388 · Cited by 23
“Johnsen et al. developed transferrin receptor-targeted immunoliposomes to facilitate cargo transport across the BBB into the brain parenchyma [143].”
Cell-penetrating peptides as facilitators of cargo-specific nanocarrier-based drug delivery
Jankowski, A. M., Ensign, M. A., & Maisel, K. (2025) · Nanoscale · doi:10.1039/d5nr00617a · Cited by 25
“Synthetic CPPs and sequences inspired by natural peptides that bind to integrins have been explored in the context of che-motherapeutic-loaded NCs. Integrins are receptors for extra-cellular matrix proteins that are generally involved in cell adhesion, di ff erentiation, and survival.”
InfluentialLongobardi, G., Moore, T. L., Conte, C., Ungaro, F., Satchi‐Fainaro, R., & Quaglia, F. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1990 · Cited by 21
The Different Cellular Entry Routes for Drug Delivery Using Cell Penetrating Peptides
Okafor, M., Schmitt, D. A., Ory, S., Gasman, S., Hureau, C., Faller, P., & Vitale, N. (2025) · Biology of the Cell · doi:10.1111/boc.70012 · Cited by 22
“These carriers can be engineered to release their contents in response to specific intracellular triggers (Walrant et al. 2013; Silva et al. 2019; Gessner and Neundorf 2020; Yang et al. 2021; Reich et al. 2024) and (v) use of light-or thermo-sensitive compounds that induce rupture of the endosomal…”
Qin, Y., Huang, M.-Y., Huang, C., Perry, H. L., Zhang, L., & Zhu, D. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109171 · Cited by 18
Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes
Korivi, M., Huang, Y., & Liu, B. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201019102640 · Cited by 18
Tarvirdipour, S., Skowicki, M., Schoenenberger, C., Kapinos, L. E., Lim, R. Y. H., Benenson, Y., & Palivan, C. G. (2022) · Biomaterials Science · doi:10.1039/d2bm00826b · Cited by 18
Faria, R., Paul, M., Biswas, S., Vivès, É., Boisguérin, P., Sousa, Â., & Costa, D. R. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040757 · Cited by 17
Thakur, D., & Kumar, L. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2548490 · Cited by 25
“…hydrophobic and hydrophilic substructures, and adjustable physicochemical characteristics, influenced by lipid selection and production procedure (Gessner and Neundorf 2020). carbon-based nanoparticles, on the other hand, have demonstrated exceptional possibilities in the biomedical field due to…”
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
Camps, E. C., van Lith, S. A. M., Frielink, C., Lankhof, J., Dijkgraaf, I., Gotthardt, M., & Brock, R. E. (2021) · Pharmaceuticals · doi:10.3390/ph14070602 · Cited by 16
“Since their discovery in the 90s [24,25] they have been employed to mediate uptake of oligonucleotides [26], peptides [27], antibodies [28,29] and nanoparticles [30,31].”
Canepa, E., Relini, A., Bochicchio, D., Lavagna, E., & Mescola, A. (2022) · Membranes · doi:10.3390/membranes12070673 · Cited by 17
A cascade-responsive nanoplatform with tumor cell-specific drug burst release for chemotherapy
He, X., Xu, B., Fang, A., Li, X., Huang, Z., Qin, S., Xiao, W., Li, G., Tian, M., Fan, N., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.02.022 · Cited by 18
Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics
Gareev, K., Tagaeva, R., Bobkov, D., Yudintceva, N., Гончарова, Д. Ф., Combs, S., Ten, A., Samochernych, K., & Shevtsov, M. (2023) · Nanomaterials · doi:10.3390/nano13071140 · Cited by 13
“The attachment of CPPs to NP surfaces can be performed via electrostatic interactions or through covalent coupling strategies [21].”
BackgroundEnvironmental Toxicity of Engineered Carbon Nanoparticles
Sharma, M. M. M., Kapoor, D., Loyal, A., Kumar, R., Sharma, P., & Husen, A. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0240-4_16 · Cited by 16
Surface-functionalised polymeric nanoparticles for breast cancer treatment: processes and advances
Prasad, A. G., Bakr, M. M., & ElMeshad, A. N. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2353359 · Cited by 16
Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs
Eissa, N. G., Elsabahy, M., & Allam, A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120317 · Cited by 17
Exploring Peptido‐Nanocomposites in the Context of Amyloid Diseases
Andrikopoulos, N., Tang, H., Wang, Y., Liang, X., Li, Y., Davis, T. P., & Ke, P. C. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309958 · Cited by 15
Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake Signal
Walter, M., Bresinsky, M., Zimmer, O., Pockes, S., & Göpferich, A. M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c07821 · Cited by 17
“3,21 In this work, we aimed to develop nanoparticles that rely on the cell uptake-enhancing properties of CPPs with utmost target cell selectivity.”
Kordbacheh, H., Eslami, S., Rezaee, A., Abadi, P. G.-S., Bybordi, S., Ehsanfar, N., Goleij, P., Sharifianjazi, F., & Irani, M. (2024) · Journal of Polymers and the Environment · doi:10.1007/s10924-024-03382-7 · Cited by 15
“Furthermore, the instability of the physicochemical properties of peptides and their storage at low temperatures hindered their application [15].”
Weaver, E., Uddin, S., Cole, D. K., Hooker, A., & Lamprou, D. A. (2021) · Applied Sciences · doi:10.3390/app11094109 · Cited by 16
“These peptide nanocarriers can possess desirable properties, including increased cell permeation [49], region-specific delivery [50] and a high degree of potential for modification based upon their unique chemical makeup.”
BackgroundPiórecka, K., Kurjata, J., & Stańczyk, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179264 · Cited by 15
“, such as gold, mesoporous silica nanoparticles, and silsesquioxanes, polymers, and dendrimers [5,6].”
BackgroundInvestigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer’s Disease
Walton-Raaby, M., Woods, R., & Kalyaanamoorthy, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119476 · Cited by 17
Complexity of the Nano-Bio Interface and the Tortuous Path of Metal Oxides in Biological Systems
Erlichman, J. S., & Leiter, J. C. (2021) · Antioxidants · doi:10.3390/antiox10040547 · Cited by 16
“arginines, have been used successfully to deliver a variety of proteins, polypeptides, nucleic acids organic/inorganic particles into the cell [126].”
BackgroundFormaggio, D. M. D., Magalhães, J. A., de Andrade, V. M., Conceição, K., Anastácio, J. M., Santiago, G. S., Arruda, D. C., & Tada, D. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071324 · Cited by 14
“This observation could be related to the mechanism of peptide binding to NPs [27].”
Background
Metadata
- Authors
- Gessner, I., & Neundorf, I.
- Affiliations
- University of Cologne (DE)
- Corresponding author
- Neundorf, Ines
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-06
- Volume
- 21
- Issue
- 7
- Pages
- 2536
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7177461
- OpenAlex
- W3014732989
- Cited by
- 212
- References
- 115
- Citations by year
- 2026: 26 · 2025: 29 · 2024: 37 · 2023: 40 · 2022: 35 · 2021: 35 · 2020: 9
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (NE 1419/10-1)
- European Commission (MSCA-ITN-ETN MAGICBULLET RELOADED 861316)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- cell-penetrating peptides, nanoparticles, surface modification, tumor-homing peptides, targeted drug delivery, cancer diagnosis, cancer therapy, cellular uptake, physicochemical properties, cationic peptides
- MeSH terms
- Theranostic Nanomedicine, Animals, Antineoplastic Agents, Drug Carriers, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles, Chemical Phenomena, Cell-Penetrating Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.